Category: Biotech

Global clinical-stage biopharmaceutical company, Connect Biopharma (Nasdaq: CNTB), has announced that post hocdata analysis from its Phase 2b CBP-201 global trial in moderate-to-severe atopic dermatitis… [Read More]

Leading cannabinoid researcher, developer and manufacturer, InMed Pharmaceuticals (Nasdaq: INM) has demonstrated the anti-inflammatory potential of rare cannabinoids in skin conditions. The company has sponsored… [Read More]

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) has met the primary and secondary endpoints in safety and pharmacokinetics in a Phase 2a clinical trial evaluating a treatment… [Read More]

ThermoGenesis Announces California Facility with Potential for $10-16M Annual Revenue ThermoGenesis Holdings (Nasdaq: THMO) will roll out a new California facility containing 12, class-7, ReadyStart… [Read More]

Protagonist Therapeutics, Inc. (Nasdaq: PTGX) has received positive topline results in its Phase 2b FRONTIER 1 clinical trial evaluating a treatment for psoriasis. The study… [Read More]

Unicycive Therapeutics, Inc., (Nasdaq: UNCY) has raised up to $130M to support its New Drug Application (NDA) submission with the FDA for approval and potential… [Read More]

Commercial-stage biopharmaceutical company, BridgeBio (Nasdaq: BBIO), has announced positive results from its PROPEL2 Phase 2 clinical trial demonstrating potential best-in-class efficacy and a clean safety… [Read More]

Lexaria Bioscience (NASDAQ: LEXX) shared the notable results of its recent diabetes animal model study, with positive outcomes including weight loss and improved triglyceride and… [Read More]

Incannex Healthcare Limited (Nasdaq: IXHL), a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic medicine therapies for unmet medical needs, has engaged a manufacturer… [Read More]

Authorities in Equatorial Guinea are working to contain an outbreak of Marburg virus that began in February 2023 and has resulted in 11 deaths and… [Read More]

Lipella Pharmaceuticals (Nasdaq: LIPO), has appointed a five-member Scientific Advisory Board in oral health to focus on the development of LP-310 for the treatment of… [Read More]

Global gene therapy company, Orchard Therapeutics (Nasdaq: ORTX) has reached an agreement that will allow reimbursed access to Libmeldy for eligible metachromatic leukodystrophy (MLD) patients… [Read More]